GYRE THERAPEUTICS, INC. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Gyre Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Gyre Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 314 %, a 27.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 314 -118 -27.3% Jun 30, 2024
Q1 2024 301 -399 -57% Mar 31, 2024
Q4 2023 267 -364 -57.7% Dec 31, 2023
Q3 2023 323 -277 -46.1% Sep 30, 2023
Q2 2023 432 -66.1 -13.3% Jun 30, 2023
Q1 2023 700 +269 +62.6% Mar 31, 2023
Q4 2022 631 +76.7 +13.8% Dec 31, 2022
Q3 2022 600 +18.1 +3.11% Sep 30, 2022
Q2 2022 498 -141 -22% Jun 30, 2022
Q1 2022 430 -267 -38.3% Mar 31, 2022
Q4 2021 554 -156 -22% Dec 31, 2021
Q3 2021 582 -27.2 -4.47% Sep 30, 2021
Q2 2021 638 -15.1 -2.31% Jun 30, 2021
Q1 2021 697 -1.87 -0.27% Mar 31, 2021
Q4 2020 710 -97.8 -12.1% Dec 31, 2020
Q3 2020 609 -1.11K -64.6% Sep 30, 2020
Q2 2020 653 -1.83K -73.7% Jun 30, 2020
Q1 2020 699 -2.69K -79.4% Mar 31, 2020
Q4 2019 808 -3.22K -79.9% Dec 31, 2019
Q3 2019 1.72K -906 -34.5% Sep 30, 2019
Q2 2019 2.48K +968 +63.9% Jun 30, 2019
Q1 2019 3.38K +2.54K +299% Mar 31, 2019
Q4 2018 4.03K +3.7K +1121% Dec 31, 2018
Q3 2018 2.63K +2.38K +954% Sep 30, 2018
Q2 2018 1.52K +1.32K +662% Jun 30, 2018
Q1 2018 847 +679 +403% Mar 31, 2018
Q4 2017 330 +160 +94.2% Dec 31, 2017
Q3 2017 249 +76 +44% Sep 30, 2017
Q2 2017 199 +17.7 +9.74% Jun 30, 2017
Q1 2017 168 -12.6 -6.97% Mar 31, 2017
Q4 2016 170 -128 -43% Dec 31, 2016
Q3 2016 173 -205 -54.2% Sep 30, 2016
Q2 2016 181 -1.34K -88.1% Jun 30, 2016
Q1 2016 181 -1.62K -89.9% Mar 31, 2016
Q4 2015 298 -1K -77.1% Dec 31, 2015
Q3 2015 378 -948 -71.5% Sep 30, 2015
Q2 2015 1.53K +529 +53.1% Jun 30, 2015
Q1 2015 1.8K +827 +85% Mar 31, 2015
Q4 2014 1.3K +236 +22.1% Dec 31, 2014
Q3 2014 1.33K +195 +17.3% Sep 30, 2014
Q2 2014 996 -288 -22.5% Jun 30, 2014
Q1 2014 973 -310 -24.2% Mar 31, 2014
Q4 2013 1.07K +321 +43.1% Dec 31, 2013
Q3 2013 1.13K +673 +147% Sep 30, 2013
Q2 2013 1.28K +962 +298% Jun 30, 2013
Q1 2013 1.28K +1.01K +378% Mar 31, 2013
Q4 2012 745 Dec 31, 2012
Q3 2012 457 Sep 30, 2012
Q2 2012 323 Jun 30, 2012
Q1 2012 269 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.